Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2006-10-30 | Mr. Seaton holds a degree in Business Studies as well as a Master of Commerce Degree from the University of New South Wales. He has 20 years experience in the pharmaceutical industry and finance. |
| 2008-10-24 | Mr. Seaton holds a degree in Business Studies as well as a Master of Commerce Degree from the University of New South Wales. He has over 20 years experience in the pharmaceutical industry. |
| 2010-02-26 | David R. Seaton is the beneficial owner of 5,000 shares of Common Stock. Mr. Seaton exercises sole voting and investment control with respect to the shares. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22